BioSpace News Archive

Shape Therapeutics® Inc. the RNA technology company advancing programmable medicine, today announced new data from its RNAfix®, RNAskipTM and AAVidTM platforms will be presented at the 25th American Society of Gene and Cell Therapy (ASGCT) Annual Meeting on May 16-19, 2022 in Washington, D.C.

Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (“Aeterna” or the “Company”), a specialty biopharmaceutical company developing and commercializing a diversified portfolio of pharmaceutical and diagnostic products, today provided an update on the positive results from pre-clinical studies of Aeterna’s Autoimmunity Modifying Biologicals (“AIM Biologicals”), for the potential treatment of Parkinson’s Disease (“PD”).

Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a late clinical stage biopharmaceutical company focused on helping patients fight cancer with oncolytic viral immunotherapies, today reported financial results for the first quarter ended March 31, 2022 and provided a corporate update.

GT Biopharma, Inc. announced that management will present at H.C. Wainwright’s Hybrid Global Investment Conference.

Amarin Corporation plc announced that Karim Mikhail, Amarin’s president and chief executive officer, will present at two upcoming investor conferences.

Bioretec Ltd has entered into a distribution agreement with AMI Medical Technologies Ltd, a leading distributor of medical devices in Israel.

Biolog, Inc., a leading provider of cell-based microbial identification and phenotypic profiling technologies, announced the appointment of a new leadership team including industry veteran Robert Wicke as Chief Executive Officer.

InDex Pharmaceuticals Holding AB announced that the company will be exhibiting at the Digestive Disease Week May 21-24, 2022 in San Diego.

Evelo Biosciences, Inc. reported financial results and business highlights for the first quarter 2022.

Fennec Pharmaceuticals Inc. reported its financial results for the fiscal quarter ended March 31, 2022 and provided a business update.